CPIX · Cumberland Pharmaceuticals Inc
$7.65
+0.15 (+2.00%)
At close · Aug 21
Market Cap
$114.62M
Shares
14.98M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | — | $1,558,849 |
| Todd Anthony | — | $355,605 |
| Chris T. Bitterman | — | $322,480 |
| John M. Hamm | — | $312,442 |
| James L. Herman | Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $224,735 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | — | $1,167,269 |
| James L. Herman | — | $349,109 |
| Todd Anthony | — | $323,752 |
| Chris T. Bitterman | — | $305,965 |
| John M. Hamm | Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $283,034 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | — | $1,189,530 |
| James L. Herman | — | $400,149 |
| Todd Anthony | — | $330,852 |
| Chris T. Bitterman | — | $316,287 |
| John M. Hamm | Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $283,951 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | — | $1,197,297 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $549,694 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $430,894 |
| James L. Herman | — | $388,188 |
| John M. Hamm | Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $308,358 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | Chief Executive Officer | $1,239,129 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $521,844 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $419,344 |
| James L. Herman | Executive Vice President and Chief Compliance Officer | $345,308 |
| Michael Bonner | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $270,815 |
| John M. Hamm | Vice President and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $227,538 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | Chief Executive Officer | $1,155,497 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $579,244 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $409,544 |
| James L. Herman | Executive Vice President and Chief Compliance Officer | $332,388 |
| Michael Bonner | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $255,666 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | Chief Executive Officer | $1,477,297 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $675,844 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $462,644 |
| James L. Herman | Executive Vice President and Chief Compliance Officer | $353,588 |
| Michael Bonner | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. Mr. Hamm was appointed as the Company's chief financial offer May 17, 2021. | $273,066 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | Chief Executive Officer | $1,475,744 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $638,244 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $414,244 |
| James L. Herman | Senior Vice President and Chief Compliance Officer | $315,748 |
| Michael Bonner | Senior Director of Finance and Accounting and Chief Financial Officer Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $242,266 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| A. J. Kazimi | Chief Executive Officer | $1,478,744 |
| Leo B. Pavliv | Executive Vice President and Chief Development Officer | $666,644 |
| Martin E. Cearnal | Executive Vice President and Chief Commercial Officer | $509,314 |
| James L. Herman | Senior Vice President and Chief Compliance Officer | $360,348 |
| Michael Bonner | Senior Director of Finance and Accounting and Chief Financial Officer The fair value of restricted stock awards granted during March 2019 equaled $5.98, the closing price of our common stock on the grant date. Represents the additions for the Named Executive Officers to the non-contributory, non-qualified defined contribution plan that provides for the payment of benefits from the general funds of the Company. Represents premiums paid for by the Company with respect to life insurance for the benefit of the Named Executive Officers. | $258,741 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James L. Herman | Vice President Trade & Distribution and Corporate Compliance Officer | Resigned | 2026-07-01 |
| Chris T. Bitterman | Vice President Sales & Marketing | Resigned | 2026-07-01 |
| Todd Anthony | Vice President of Organizational Development | Appointed | 2023-03-15 |
| John Hamm | Chief Financial Officer | Appointed | 2023-03-15 |
| James "Jim" Herman | Executive Vice President National Accounts & Chief Compliance Officer | Appointed | 2023-03-15 |
| Martin S. Brown Jr | member of its Board of Directors | Appointed | 2022-07-19 |
| Leo Pavliv | Executive Vice President, Chief Development & Operations Officer | Retired | 2022-06-03 |
| John Hamm | Senior Director Finance & Accounting and Chief Financial Officer | Appointed | 2021-05-14 |
| Kenneth J. Krogulski | Class I Director | Appointed | 2020-05-08 |
| Jonathan I. Griggs | Class II Director | Appointed | 2020-05-08 |
| Caroline R. Young | Class I Director | Appointed | 2020-05-08 |
| Joey A. Jacobs | Class I Director | Appointed | 2020-05-08 |
Key facts
CIK
1087294
CUSIP
230770109
13F (30d)
32 filings
32 filers
Visit website
Investor relations